UBE Corporation
- Biotech or pharma, therapeutic R&D
UBE Corporation is a leading Japanese chemical and drug discovery company with extensive expertise in small molecule therapeutics. Founded over a century ago, UBE specializes in the research, development, and licensing of innovative pharmaceutical compounds to biotechnology and pharmaceutical industry partners.
At BIO2025, we aim to:
Meeting with potential partners seeking cutting-edge ADC linker technology to enhance their antibody therapeutics pipeline:
- Establish research collaborations utilizing UBE’s proprietary ADC platform, featuring our novel UVH linker and advanced payload technology, to enhance antibody-drug conjugate (ADC) development programs.
Identify strategic partners for our clinical candidates.
- UD-086 (Auristatin E Prodrug-HER2 ADC),
- PPMX-T004b_PGAP (Auristatin E prodrug-CDH3 ADC)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}